Analyst Ratings For Celgene Corporation (NASDAQ:CELG)
Today, Cann reiterated its Buy rating on Celgene Corporation (NASDAQ:CELG) with a price target of $175.00.
There are 1 sell rating, 4 hold ratings, 21 buy ratings on the stock.
The current consensus rating on Celgene Corporation (NASDAQ:CELG) is Buy (Score: 2.77) with a consensus target price of $147.07 per share, a potential 8.80% upside.
Some recent analyst ratings include
- 8/1/2017-Cann Reiterated Rating of Buy.
- 7/31/2017-Jefferies Group LLC Reiterated Rating of Buy.
- 7/31/2017-Oppenheimer Holdings, Inc. Reiterated Rating of Outperform.
- 7/31/2017-Argus Upgrade from a “Hold ” rating to a ” Buy” rating.
- 7/28/2017-Barclays PLC Reiterated Rating of Hold.
- 7/28/2017-BMO Capital Markets Reiterated Rating of Outperform.
- 7/28/2017-Leerink Swann Reiterated Rating of Outperform.
Recent Insider Trading Activity For Celgene Corporation (NASDAQ:CELG)
Celgene Corporation (NASDAQ:CELG) has insider ownership of 0.95% and institutional ownership of 78.39%.
- On 6/26/2017 James J Loughlin, Director, sold 18,500 with an average share price of $133.57 per share and the total transaction amounting to $2,471,045.00. View SEC Filing
- On 6/22/2017 Michael A Friedman, Director, sold 10,000 with an average share price of $132.50 per share and the total transaction amounting to $1,325,000.00. View SEC Filing
- On 6/22/2017 Robert J Hugin, Insider, sold 175,970 with an average share price of $134.14 per share and the total transaction amounting to $23,604,615.80. View SEC Filing
- On 6/21/2017 Michael D Casey, Director, sold 9,250 with an average share price of $133.05 per share and the total transaction amounting to $1,230,712.50. View SEC Filing
- On 6/19/2017 Michael D. Casey, Director, sold 9,250 with an average share price of $125.59 per share and the total transaction amounting to $1,161,707.50. View SEC Filing
- On 6/15/2017 Rupert Vessey, Insider, sold 4,785 with an average share price of $120.18 per share and the total transaction amounting to $575,061.30. View SEC Filing
- On 5/1/2017 James J Loughlin, Director, sold 9,250 with an average share price of $124.00 per share and the total transaction amounting to $1,147,000.00. View SEC Filing
Recent Trading Activity for Celgene Corporation (NASDAQ:CELG)
Shares of Celgene Corporation closed the previous trading session at 135.18 down -0.23 -0.17% with 4,266,890 shares trading hands.